D. Carter

Convergent evolution of pain-inducing defensive venom components in spitting cobras

P. Dorrestein, J. Calvete, I. Vetter, 2020, Science.

High-Throughput Fluorescence Assays for Ion Channels and GPCRs.

I. Vetter, S. Robinson, D. Carter, 2020, Advances in experimental medicine and biology.

Characterisation of a Novel A-Superfamily Conotoxin

I. Vetter, A. Nicke, N. Daly, 2020, Biomedicines.

Modeling heart failure risk in diabetes and kidney disease: limitations and potential applications of transverse aortic constriction in high-fat-fed mice.

D. Carter, H. Bielefeldt-Ohmann, K. Moritz, 2018, American journal of physiology. Regulatory, integrative and comparative physiology.

Validation of non‐invasive transcutaneous measurement for glomerular filtration rate in lean and obese C57BL/6J mice

D. Carter, L. Gallo, Wei Sheng Tan, 2020, Nephrology.

Sotagliflozin, a dual SGLT1/2 inhibitor, improves cardiac outcomes in a mouse model of early heart failure without diabetes

D. Carter, H. Bielefeldt-Ohmann, S. L. Walton, 2020, bioRxiv.

Low potency inhibition of NaV1.7 by externally applied QX-314 via a depolarizing shift in the voltage-dependence of activation.

I. Vetter, T. Durek, D. Carter, 2022, European journal of pharmacology.

Inflammatory and neuropathic gene expression signatures of chemotherapy-induced neuropathy induced by vincristine, cisplatin and oxaliplatin in C57BL/6J mice.

I. Vetter, D. Carter, J. Deuis, 2019, The journal of pain : official journal of the American Pain Society.